A Complete Guide to Immortalized Cancer Cell Lines in Cancer Research

In modern life sciences and drug discovery, immortalized cancer cell lines are virtually indispensable. From exploring molecular mechanisms and screening new drugs to studying tumor immunology and verifying personalized treatment strategies, these cell lines serve as one of the most essential "laboratory models" for biomedical research.

What Are Immortalized Cancer Cell Lines?

In their natural environment, almost all mammalian cells have limited proliferative potential - after reaching a certain number of cell divisions, they die by apoptosis or enter a senescent state. The maximum number of divisions is called the Hayflick limit.

Cancer cells, due to genetic mutations, develop the ability to proliferate uncontrolled and infinite number of times and therefore, in principle, can be cultured in vitro indefinitely.

The continuous division ability of cancer cells allows researchers to create immortalized cell lines that sustain growth and maintain stability in laboratory cultures.

The cells are usually taken from a human or animal tumor tissue. With the help of selection and long-term culturing, they create genetically stable, easy-to-culture, and homogeneous cell populations that are phenotypically very similar and can be maintained for long periods of time.

A Historical Milestone: The Story of HeLa Cells

The oldest immortalized human cancer cell line, and one of the most famous, is the HeLa cell line, isolated from the cervical cancer of Henrietta Lacks, at Johns Hopkins Hospital, Baltimore, in 1951.

To the researchers' surprise, the cells did not die in the manner of normal cells in culture, but divided continuously, proliferating very rapidly. Dr. George Gey was able to create the first immortalized human cell line in the world - HeLa.

HeLa cells revolutionized modern cell biology and have since been instrumental in:

• The development of the polio vaccine;
• Research in virology, oncogenesis, and cytogenetics;
• The establishment of drug toxicity and efficacy evaluation systems.

The creation of HeLa cells marked the beginning of the in vitro immortalization era and provided the foundation and inspiration for the establishment of countless other cell lines.

How Immortalized Cancer Cell Lines Are Established

There are several methods by which cancer cell lines can be immortalized:

• Spontaneous immortalization - some cells derived from tumors are able to escape senescence spontaneously during in vitro culturing.
• Viral-mediated immortalization - overexpression of viral oncogenes that target cell cycle regulatory genes (e.g., SV40 large T antigen, HPV E6/E7).
• Telomerase activation - overexpression of hTERT to sustain telomere length and cell proliferation.
• Gene editing and hybridization - fusion of cells with already immortalized cells or precise editing of tumor suppressor genes or pathways that act as barriers to immortalization (e.g., p53, Rb)

In all cases, the conditions applied to immortalize the cells are carefully modulated to maintain unlimited proliferation but retain the genetic and phenotypic features of the original cell type as much as possible.

Commonly Used Immortalized Cancer Cell Lines and Their Applications

In the past decades, thousands of immortalized cancer cell lines have been established from a variety of tumor types. Below are some of the most commonly used models, organized by cancer origin, with their main applications:

Breast Cancer Cell Lines

Breast cancer cell lines are essential for studying tumor heterogeneity and developing personalized therapies.

• MCF-7: A classic estrogen receptor-positive (ER+) model, widely used for testing endocrine therapies (e.g., tamoxifen) and investigating hormone-dependent signaling pathways.
• MDA-MB-231: A popular TNBC model with high invasiveness and is typically used in metastasis formation, chemoresistance, and validation of immunotherapy targets.
• SK-BR-3: A HER2-overexpressing model commonly used for assessing anti-HER2 therapeutics such as trastuzumab and studying dysregulation of the receptor signaling.

Lung Cancer Cell Lines

Lung cancer models have seen the most widespread use in precision medicine applications for many driver mutations.

• A549: A non-small cell lung adenocarcinoma model often used for anti-cancer drug screening, inflammation studies, and drug delivery.
• PC-9: A model carrying the EGFR exon 19 deletion mutation, often used to test EGFR TKIs and resistance mechanisms.
• H1299: A p53-null cell line often used for studying tumorigenesis and signaling pathway in the absence of p53.

Gastrointestinal Cancer Cell Lines

These cells are useful for studying metabolism, intestinal barrier function, and drug absorption.

• HepG2 (Liver Cancer): A model that maintains many hepatic metabolic and synthetic functions. The most common in toxicology, pharmacokinetics, and nutrition studies.
• HCT116 (Colon Cancer): A p53-functional line most often used in apoptosis, DNA damage repair, and development of KRAS inhibitors.
• Caco-2 (Colon Cancer): Differentiates spontaneously in culture to polarized monolayers with microvilli. The most common in vitro model of intestinal permeability.

Urogenital System Cell Lines

Used in modeling of hormone-dependent cancers, therapy resistance, and other processes.

• LNCaP (Prostate Cancer): An androgen receptor-positive (AR+) and androgen-sensitive line often used for modeling hormone-driven tumor growth and castration-resistant prostate cancer (CRPC).
• PC-3 (Prostate Cancer): An androgen-independent and highly metastatic model more appropriate for studying metastasis mechanisms and chemotherapy.
• SKOV3 (Ovarian Cancer): One of the most common models for testing platinum resistance, peritoneal metastasis, and novel targeted therapies.

Hematological Malignancy Cell Lines

Used for modeling of leukemia and lymphoma biology.

• K562 (Chronic Myelogenous Leukemia): A model positive for the Philadelphia chromosome (BCR-ABL fusion gene) used to test TKIs like imatinib.
• Jurkat (T-cell Leukemia): A T-cell signaling model often used for apoptosis and in vitro CAR-T cytotoxicity assessment.

Pros and Cons of Immortalized Cancer Cell Lines

Pros

• Unlimited proliferation: Immortalized cell lines provide an inexhaustible source of uniform biological material, essential for reproducibility.
• Stable biological properties: They maintain important cancer characteristics (such as dysregulated cell cycle and apoptosis resistance) that are valuable for mechanistic studies.
• Ease of use in the lab: They are convenient to grow, manipulate, and genetically modify for various experimental approaches, including gene editing, drug screening, and pathway analysis.
• Wide availability: There is a large collection of immortalized cancer cell lines available to scientists, each representing different cancer types. This allows researchers to choose cell lines that are most appropriate for their specific research goals.

Cons

• Physiological relevance: The absence of immune, vascular, and stromal elements in cell culture systems may limit the physiological relevance of the data obtained from these models.
• Genetic drift: The extended culture and adaptation of cells in vitro can lead to genetic and phenotypic changes, potentially affecting the reproducibility and reliability of experimental results.
• Lack of tumor heterogeneity: Most immortalized cancer cell lines are derived from a single cell clone, which means they do not capture the heterogeneity present in actual tumors.
• Cross-contamination and misidentification: There have been issues with cross-contamination between different cell lines and misidentification, highlighting the need for regular authentication.

Creative Bioarray Relevant Recommendations